CHEMOTHERAPEUTIC, CARCINOGENIC, AND CELL-REGULATORY EFFECTS OF TRIAZENES = EFFETS CHIMIOTHERAPIQUES, CANCERIGENES ET REGULATEURS CELLULAIRES DES TRIAZENESSCHMID FA; HUTCHISON DJ.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 7; PP. 1671-1675; BIBL. 12 REF.Article

EFFECT OF DIFFERENT DOSES OF METHOTREXATE (NSC-740), CYTOSINE ARABINOSIDE (NSC-63878), AND CYCLOPHOSPHAMIDE (NSC-26271) ON DRUG RESISTANCE IN MICE WITH L1210 LEUKEMIASCHMID FA; HUTCHISON DJ.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 4; PP. 473-481; BIBL. 20REF.Serial Issue

DRUG RESISTANCE IN LEUKEMIA.HUTCHISON DJ; SCHMID FA.1976; ANTIBIOT. AND CHEMOTHERAPY; SWITZ.; DA. 1976; VOL. 20; PP. 227-245; BIBL. 2 P. 1/2Article

ANTINEOPLASTIC AND TOXIC EFFECTS OF ACINETOBACTER AND PSEUDOMONAS GLUTAMINASE-ASPARAGINASESSCHMID FA; ROBERTS J.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 829-840; BIBL. 27REF.Article

CRYOFRAGILITY AND OTHER MEMBRANE CHARACTERISTICS OF SOLID MOUSE TUMORSSCHMID FA; OTTER GM; HUTCHISON DJ et al.1981; CRYOBIOLOGY; ISSN 0011-2240; USA; DA. 1981; VOL. 18; NO 3; PP. 244-250; BIBL. 24 REF.Article

IN VIVO EFFECTS OF PHENYLALANINE AMMONIA-LYASEROBERTS J; SCHMID FA; TAKAI K et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 261-263; BIBL. 6 REF.Article

BIOLOGIC AND ANTINEOPLASTIC EFFECTS OF ENZYME-MEDIATED IN VIVO DEPLETION OF L-GLUTAMINE, L-TRYPTOPHAN, AND L-HISTIDINEROBERTS J; SCHMID FA; ROSENFELD HJ et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 6; PP. 1045-1054; BIBL. 35 REF.Article

EFFECT OF COMPOUNDS ON A SPECTRUM OF RAT TUMORSSUGIURA K; SCHMID FA; SCHMID MM et al.1972; CANCER CHEMOTHERAPY REP., 2; U.S.A.; DA. 1972; VOL. 3; NO 1; PP. 231-308; BIBL. 1P.1/2Serial Issue

ANTITUMOR TESTS OF AMYGDALIN IN TRANSPLANTABLE ANIMAL TUMOR SYSTEMS.STOCK CC; TARNOWSKI GS; SCHMID FA et al.1978; J. SURG. ONCOL.; U.S.A.; DA. 1978; VOL. 10; NO 2; PP. 81-88; BIBL. 11 REF.Article

A COMPARATIVE STUDY OF THE ANTITUMOR EFFECTIVENESS OF E. COLI AND ERWINIA ASPARAGINASESROBERTS J; SCHMID FA; OLD LJ et al.1976; CANCER BIOCHEM. BIOPHYS.; G.B.; DA. 1976; VOL. 1; NO 4; PP. 175-178; BIBL. 17 REF.Article

CHEMOTHERAPEUTIC EFFECTS OF COMPOUND 593A (NSC-135758) ON MOUSE LEUKEMIAS AND SOME TRANSPLANTED ANIMAL TUMORSTARNOWSKI GS; SCHMID FA; HUTCHINSON DJ et al.1973; CANCER CHEMOTHERAPY REP., I; U.S.A.; DA. 1973; VOL. 57; NO 1; PP. 21-27; BIBL. 9REF.Serial Issue

ANTITUMOR TESTS OF AMYGDALIN IN SPONTANEOUS ANIMAL TUMOR SYSTEMS.STOCK CC; MARTIN DS; SUGIURA K et al.1978; J. SURG. ONCOL.; U.S.A.; DA. 1978; VOL. 10; NO 2; PP. 89-123; BIBL. 5 REF.Article

BIOCHEMICAL EFFECTS OF 2'-FLURO-5-METHYL-1-BETA -D-ARABINOFURANOSYLURACIL AND 2'-FLUORO-5-IODO-1-BETA -D-ARABINOFURANOSYL CYTOSINE IN MOUSE LEUKEMIC CELLS SENSITIVE AND RESISTANT TO 1-BETA -D-ARABINOFURANOSYLCYTOSINETING CHAO CHOU; BURCHENAL JH; SCHMID FA et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 10; PP. 3957-3963; BIBL. 32 REF.Article